Listed

ICU Medical Inc

ICUINasdaqCIK 883984HealthcareFiscal year ends Dec 31

Reports and events: 280 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

ICU Medical Inc, Reports and events
FiledFormWhat it isAccession number
2022-08-0816:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-22-000039
2022-05-1810:21 ET8-K5.07 Shareholder vote results0000883984-22-000032
2022-05-0917:15 ET10-QQuarterly reportPeriod 2022-03-310000883984-22-000030
2022-05-0916:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-22-000029
2022-04-2017:24 ET8-K5.02 Departure or appointment of officers or directors0000883984-22-000026
2022-04-0416:40 ETDEF 14AProxy statementPeriod 2022-04-040000883984-22-000023
2022-03-2116:09 ET8-K/A9.01 Financial statements and exhibits0000883984-22-000020
2022-02-2516:53 ET10-KAnnual reportPeriod 2021-12-310000883984-22-000014
2022-02-2416:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-22-000012
2022-02-1808:57 ET8-K5.02 Departure or appointment of officers or directors0000883984-22-000009
2022-02-0109:00 ET8-K5.02 Departure or appointment of officers or directors0000883984-22-000007
2022-01-1216:30 ETSC 13DOwnership report, active investor0000950127-22-000003
2022-01-0708:59 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0000883984-22-000005
2022-01-0416:32 ET8-K5.02 Departure or appointment of officers or directors0000883984-22-000002
2021-11-0517:01 ET10-QQuarterly reportPeriod 2021-09-300000883984-21-000033
2021-11-0316:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-21-000031
2021-09-2817:03 ET8-K8.01 Other events0000883984-21-000029
2021-09-0809:08 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-267387
2021-08-0908:14 ET8-K8.01 Other events0000883984-21-000027
2021-08-0416:33 ET10-QQuarterly reportPeriod 2021-06-300000883984-21-000025
2021-08-0416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-21-000024
2021-07-0716:14 ET8-K5.02 Departure or appointment of officers or directors0000883984-21-000020
2021-05-1413:29 ET8-K5.07 Shareholder vote results0000883984-21-000016
2021-05-0713:42 ET10-QQuarterly reportPeriod 2021-03-310000883984-21-000014
2021-05-0616:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-21-000012
2021-04-0114:44 ETDEF 14AProxy statementPeriod 2021-04-010000883984-21-000009
2021-02-2616:59 ET10-KAnnual reportPeriod 2020-12-310000883984-21-000005
2021-02-2516:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-21-000002
2020-11-0615:27 ET10-QQuarterly reportPeriod 2020-09-300000883984-20-000038
2020-11-0516:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-20-000037
2020-08-1016:20 ET10-QQuarterly reportPeriod 2020-06-300000883984-20-000034
2020-08-1016:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-20-000033
2020-05-1517:44 ET8-K5.07 Shareholder vote results0000883984-20-000026
2020-05-0816:03 ET10-QQuarterly reportPeriod 2020-03-310000883984-20-000021
2020-05-0716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-20-000019
2020-04-0312:49 ETDEF 14AProxy statementPeriod 2020-04-030000883984-20-000016
2020-03-0208:35 ET10-KAnnual reportPeriod 2019-12-310000883984-20-000014
2020-02-2816:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000883984-20-000010
2020-02-2716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-20-000005
2020-01-0612:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000883984-20-000002
2019-11-1216:38 ET10-QQuarterly reportPeriod 2019-09-300000883984-19-000035
2019-11-1212:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-19-000031
2019-08-0915:42 ET10-QQuarterly reportPeriod 2019-06-300000883984-19-000029
2019-08-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-19-000026
2019-07-0817:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000883984-19-000024
2019-05-1612:59 ET8-K5.07 Shareholder vote results0000883984-19-000019
2019-05-1016:04 ET10-QQuarterly reportPeriod 2019-03-310000883984-19-000017
2019-05-0916:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000883984-19-000015
2019-04-0512:02 ETDEF 14AProxy statementPeriod 2019-05-150000883984-19-000011
2019-04-0511:43 ET8-K5.02 Departure or appointment of officers or directors0000883984-19-000009

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.